查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1683380

全球智慧支架市场 - 2025 至 2033 年

Global Smart Stents Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球智慧支架市场规模达 23 亿美元，预计到 2033 年将达到 40.1 亿美元，2025-2033 年预测期内的复合年增长率为 5.7%。

智慧支架是一种先进的医疗设备，用于治疗身体血管或其他管状结构的阻塞或狭窄。与仅提供结构支撑以保持血管畅通的传统支架不同，智慧支架配备了整合感测器和技术，可实现即时监控和增强功能。这些感测器可以追踪各种生理参数，如血流、压力、温度或组织氧水平，在手术期间和手术后为医疗专业人员提供宝贵的资料。

市场动态：

驱动因素与约束因素

微创手术需求不断成长

对微创手术的需求不断增长，预计将推动智慧支架市场的发展，使这些先进的设备更受医疗保健提供者和患者的青睐。微创手术有切口小、恢復时间短、术后疼痛少等优点，正成为治疗心血管疾病、肾臟疾病和其他血管疾病的首选方法。例如，根据克利夫兰诊所的研究，美国的医疗保健提供者每年执行约 60 万例冠状动脉支架手术。

智慧支架整合了感测器，可用于即时监测、药物传输和提高手术精度，与微创治疗日益增长的趋势完美契合。这些支架使外科医生能够监测动脉或血管的状况，降低併发症的风险，改善患者的治疗效果，同时最大限度地减少更大、更具侵入性的手术的需要。随着对最大限度减少创伤和恢復时间的手术的需求不断增长，智慧支架将在推动市场发展方面发挥关键作用。

智慧支架成本高昂

智慧感测器的高成本预计将限制其普及性，从而阻碍智慧支架市场的发展。智慧支架采用了先进的感测器技术，可以实现即时监测和资料传输，但这些感测器的开发和製造成本很高。增加的生产成本通常会转嫁给医疗保健提供者和患者，从而使智慧支架的价格明显高于传统支架。这可能会导致采用率下降，特别是在医疗保健预算有限的发展中国家。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 微创手术需求不断成长
      • 慢性病发生率上升
    • 限制
      • 智慧感测器成本高昂
      • 监管挑战
    • 机会
      • 不断进步的技术
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：按类型

  • 心血管智慧支架
  • 泌尿科智慧支架
  • 胆道智慧支架
  • 呼吸智慧支架
  • 其他的

第 7 章：按最终用户

  • 医院
  • 门诊手术中心 (ASC)
  • 专科诊所

第 8 章：按地区

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第九章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第十章：公司简介

  • Cordis
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Boston Scientific Corporation
  • Abbott
  • Medtronic
  • Balton
  • Biotronik

第 11 章：附录

简介目录
Product Code: MD9320

The global smart stents market reached US$ 2.3 billion in 2024 and is expected to reach US$ 4.01 billion by 2033, growing at a CAGR of 5.7% during the forecast period 2025-2033.

Smart stents are advanced medical devices designed to treat blockages or narrowing in blood vessels or other tubular structures in the body. Unlike traditional stents, which simply provide structural support to keep blood vessels open, smart stents are equipped with integrated sensors and technology that enable real-time monitoring and enhanced functionality. These sensors can track various physiological parameters such as blood flow, pressure, temperature, or tissue oxygen levels, providing valuable data to healthcare professionals during and after procedures.

Market Dynamics: Drivers & Restraints

Increasing Demand for Minimally Invasive Procedures

The increasing demand for minimally invasive procedures is expected to drive the smart stents market by making these advanced devices more desirable for both healthcare providers and patients. Minimally invasive procedures, which offer benefits such as smaller incisions, reduced recovery times, and less post-operative pain, are becoming the preferred option for treating conditions like cardiovascular disease, kidney disorders, and other vascular issues. For instance, according to the Cleveland Clinic study, each year, healthcare providers in the United States perform about 600,000 coronary stent procedures.

Smart stents, which integrate sensors for real-time monitoring, drug delivery, and enhanced precision during surgery, align perfectly with the growing trend toward minimally invasive treatments. These stents enable surgeons to monitor the condition of the artery or vessel, reduce the risk of complications, and improve patient outcomes, all while minimizing the need for larger, more invasive surgeries. As the demand for procedures that minimize trauma and recovery time continues to grow, smart stents are positioned to play a key role in driving the market.

High Costs of Smart Stents

The high costs of smart sensors are expected to hinder the smart stents market by limiting their accessibility. Smart stents incorporate advanced sensor technologies that enable real-time monitoring and data transmission, but these sensors are expensive to develop and manufacture. The increased production costs are often passed on to healthcare providers and patients, making smart stents significantly more expensive than traditional stents. This can lead to a slower adoption rate, particularly in developing countries where healthcare budgets are limited.

Segment Analysis

The global smart stents market is segmented based on the type, end-user and region.

Cardiovascular smart stents in the type segment is expected to dominate the smart stents market

Cardiovascular smart stents are expected to dominate the smart stents market due to the high prevalence of cardiovascular diseases (CVDs) and the increasing adoption of minimally invasive procedures. Cardiovascular diseases, including coronary artery disease and heart attacks, are among the leading causes of death globally, creating a substantial need for effective treatment options. Smart stents in this segment offer enhanced benefits such as real-time monitoring of blood flow, pressure, and vessel conditions, as well as drug delivery systems that can reduce the risk of restenosis (re-narrowing of the arteries). These advanced features provide more precise treatment, better patient outcomes, and faster recovery times, making them highly sought after in the cardiovascular space.

Additionally, with significant advancements in technology and increasing demand for minimally invasive surgeries, cardiovascular smart stents offer a compelling solution for both patients and healthcare providers. For instance, in May 2024, Abbott launched the XIENCE Sierra Everolimus Eluting Coronary Stent System in India, further solidifying its dominance in the cardiovascular smart stents segment. As part of the renowned XIENCE family, the XIENCE Sierra is one of the latest-generation stents designed to treat patients with blocked coronary arteries. This advanced stent system offers unparalleled safety and precision, making it especially effective for the most complex cases encountered by interventional cardiologists. The launch of this next-generation smart stent underscores the continued growth and innovation within the cardiovascular sector.

This combination of high demand for effective cardiovascular treatments and the benefits of advanced smart stent technologies is driving their dominance in the market.

Geographical Analysis

North America is expected to dominate the smart stents market

North America is expected to dominate the smart stents market due to high demand for minimally invasive procedures, and great ability in medical device innovation. The region's healthcare system is quick to adopt cutting-edge technologies, including smart stents, which align with the growing trend toward less invasive surgeries that offer faster recovery and better outcomes.

Leading market players in the region are driving innovation and development in this market. Additionally, North America's region gaining strong regulatory approvals, strong research and development investments and aging population with increasing chronic diseases create a significant demand for smart stents. For instance, in March 2022, Cordis received approval for the S.M.A.R.T. RADIANZ Vascular Stent System by the U.S. Food and Drug Administration (FDA). This self-expanding stent is specifically engineered for radial peripheral procedures, allowing for precise and efficient placement in the iliac and superficial femoral arteries (SFA). The approval of this innovative stent system enhances the existing RADIANZ(TM) Radial Peripheral System, which also includes the BRITE TIP RADIANZ(TM) Guiding Sheath and SABERX RADIANZ PTA Catheter. This comprehensive system is designed to optimize radial access, improve procedural outcomes, and provide high levels of patient satisfaction.

The launch of such cutting-edge technologies further strengthens the growing role of smart stents in minimally invasive treatments, marking a major step forward in the smart stents market. These factors are expected to combinedly drive the region's growth.

Competitive Landscape

The global market players in the smart stents market are Cordis, Boston Scientific Corporation, Abbott, Medtronic, Balton, and Biotronik., among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Minimally Invasive Procedures
      • 4.1.1.2. Rising Incidence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs of Smart Sensors
      • 4.1.2.2. Regulatory Challenges
    • 4.1.3. Opportunities
      • 4.1.3.1. Rising Technological Advancements
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest-selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Cardiovascular Smart Stents*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Urological Smart Stents
  • 6.4. Biliary Smart Stents
  • 6.5. Respiratory Smart Stents
  • 6.6. Others

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers (ASCs)
  • 7.4. Specialty Clinics

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Spain
      • 8.3.5.5. Italy
      • 8.3.5.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Mexico
      • 8.4.5.2. Brazil
      • 8.4.5.3. Argentina
      • 8.4.5.4. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. South Korea
      • 8.5.5.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

  • 10.1. Cordis*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Boston Scientific Corporation
  • 10.3. Abbott
  • 10.4. Medtronic
  • 10.5. Balton
  • 10.6. Biotronik

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us